The first companion diagnostic tests were designed for therapeutics used in treating breast cancers resulting from over-expression of the HER2/neu receptor.…
The first companion diagnostic tests were designed for therapeutics used in treating breast cancers resulting from over-expression of the HER2/neu receptor.…